Supportive Care in Lung Cancer

Seminars in Oncology Nursing

Volumn 24, Issue 1, 2008, Pages 57-67

  Joyce, Margaret ^a   Schwartz, Sue ^a   Huhmann, Maureen ^a  

^a NONE

Author keywords

anorexia; cachexia; cough; dyspnea; fatigue; Lung cancer; pain; palliative care; psychosocial distress

Indexed keywords

ANOREXIA; ARTICLE; CACHEXIA; COUGHING; DYSPNEA; FATIGUE; HUMAN; LUNG TUMOR; MENTAL STRESS; NURSING; PAIN; PSYCHOLOGICAL ASPECT;

ANOREXIA; CACHEXIA; COUGH; DYSPNEA; FATIGUE; HUMANS; LUNG NEOPLASMS; PAIN; STRESS, PSYCHOLOGICAL;

EID: 38349163383     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2007.11.013     Document Type: Article

References (88)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. v.1.2007. Palliative care. Available at: http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf (accessed Dec 18, 2007).
3. Cooley M.E. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage 19 (2000) 137-153
4. Fox S.W., and Lyon D.E. Symptom clusters and quality of life in survivors of lung cancer. Oncol Nurs Forum 33 (2006) 931-936
5. Chan C.W., Richardson A., and Richardson J. A study to assess the existence of the symptom cluster of breathlessness, fatigue and anxiety in patients with advanced lung cancer. Eur J Oncol Nurs 9 (2005) 325-333
6. Gift A.G., Stommel M., Jablonski A., and Given W. A cluster of symptoms over time in patients with lung cancer. Nurs Res 52 (2003) 393-400
7. Gift A.G., Jablonski A., Stommel M., et al. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum 31 (2004) 202-212
8. Mitchell S.A., Beck S.L., Hood L.E., et al. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 11 (2007) 99-113
9. Kim Y., Hickok J.T., and Morrow G. Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manage 32 (2006) 311-321
10. Munch T.N., Stromgren A.S., Pedersen L., et al. Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the multidimensional fatigue inventory. J Pain Symptom Manage 31 (2006) 533-541
11. Tanaka K., Akechi T., Okuyama T., et al. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage 23 (2002) 417-423
12. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. v.4.2007. Cancer-related fatigue. Available at: www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf (accessed Dec 18, 2007).
13. Johnston M.P., and Coward D.D. Cancer-related fatigue: nursing assessment and management: increasing awareness of the effect of cancer-related fatigue. Am J Nurs 101 suppl (2001) 19-22
14. Kaasa S., Loge J.H., Knobel H., et al. Fatigue. Measures and relation to pain. Acta Anaesthesiol Scand 43 (1999) 939-947
15. Cella D.F., Bonomi A.E., Lloyd S.R., et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12 (1995) 199-220
16. Hollen P.J., Gralla R.J., Kris M.G., et al. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 29A suppl 1 (1993) S51-S58
17. Mendoza T., Wang X., Cleeland C., et al. The rapid assessment of fatigue severity in cancer patients. Cancer 85 (1999) 1186-1196
18. Stricker C.T., Drake D., Hoyer K.A., et al. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention. Oncol Nurs Forum 31 (2004) 963-976
19. Barsevick A.M., Dudley W., Beck S., et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer 100 (2004) 1302-1310
20. Nail L.M. Fatigue in patients with cancer. Oncol Nurs Forum 29 (2002) 537-546
21. Morrow G.R., Shelke A.R., Roscoe J.A., et al. Management of cancer-related fatigue. Cancer Invest 23 (2005) 229-239
22. Beach P., Siebeneck B., Buderer N.F., et al. Relationship between fatigue and nutritional status in patients receiving radiation therapy to treat lung cancer. Oncol Nurs Forum 28 (2001) 1027-1031
23. Yang Y.H. Relationship between fatigue and nutritional status in patients with cancer undergoing radiotherapy. Taehan Kanho Hakhoe Chi 33 (2003) 478-487
24. Gramignano G., Lusso M.R., Madeddu C., et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22 (2006) 136-145
25. Wells M., Sarna L., Cooley M.E., et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs 30 (2007) 45-55
26. Administration USFaD. Information on erythropoiesis stimulating agents (ESA). Available at: http://fda.gov/cder/drug/infopage?RHE/default.htm. (accessed Dec 18, 2007).
27. Barnes E.A., and Bruera E. Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer 12 (2002) 424-428
28. Hopwood P., and Stephens R.J. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer 71 (1995) 633-636
29. Dudgeon D.J., Kristjanson L., Sloan J.A., et al. Dyspnea in cancer patients: Prevalence and associated factors. J Pain Symptom Manage (2001) 2195-2102
30. Ripimonti C., and Fusco F. Respiratory problems in supportive care. Cancer 10 (2002) 204-216
31. Brown M.L., Carrieri V., Janson B., et al. Lung cancer and dyspnea: the patient's perception. Oncol Nurs Forum 13 (1986) 19-24
32. O'Driscoll M., Corner J., and Bailey C. The experience of breathlessness in lung cancer. Eur J Cancer Care (Engl) 8 (1999) 37-43
33. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159 (1999) 321-340
34. Dudley D.L., Martin C.J., and Holmes T.H. Psychophysiologic studies of pulmonary ventilation. Psychosom Med 26 (1964) 645-660
35. Gift A.G. Psychologic and physiologic aspects of acute dyspnea in asthmatics. Nurs Res 40 (1991) 196-199
36. Smith E.L., Hann D.M., Ahles T.A., et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage 21 (2001) 323-329
37. Chetta A., Gerra G., Foresi A., et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med 157 (1998) 116-122
38. Joyce M, Beck SL. Measuring oncology nursing-sensitive patient outcomes: evidence based summary. Available at: http://onsopcontent.ons.org/toolkits/evidence/Clinical/pdf/DyspneaTools.pdf (accessed July 24, 2005).
39. Houlihan N.G., Inzeo D., Joyce M., et al. Symptom management of lung cancer. Clin J Oncol Nurs 8 (2004) 645-652
40. Bruera E., de Stoutz N., Velasco-Leiva A., et al. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet 342 (1993) 13-14
41. Bruera E., Sweeney C., Willey J., et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med 17 (2003) 659-663
42. Dudgeon D.J. Managing dyspnea and cough. Hematol Oncol Clin North Am 16 (2002) 557-577
43. Jennings A.L., Davies A.N., Higgins J.P., et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax 57 (2002) 939-944
44. Allard P., Lamontagne C., Bernard P., et al. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage 17 (1999) 256-265
45. Joyce M., McSweeney M., Carrieri-Kohlman V.L., et al. The use of nebulized opioids in the management of dyspnea: evidence synthesis. Oncol Nurs Forum 31 (2004) 551-561
46. Coyne P.J., Viswanathan R., and Smith T.J. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage 23 (2002) 157-160
47. Kohara H., Ueoka H., Aoe K., et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J Pain Symptom Manage 26 (2003) 962-967
48. Campbell M.L. Terminal dyspnea and respiratory distress. Crit Care Clin 20 (2004) 403-417
49. Ripamonti C. Management of dyspnea in advanced cancer patient. Support Care Cancer 7 (1999) 233-243
50. Bredin M., Corner J., Krishnasamy M., et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 318 (1999) 901-904
51. Kvale P.A., Simoff M., and Prakash U.B. Palliative care. Chest 123 (2003) 284S-311S
52. Tyson L.B. Cough. In: Camp-Sorrell D., and Hawkins R. (Eds). Clinical manual for the oncology advanced practice nurse. Ed 2. (2006), Oncology Nursing Society, Pittsburgh, PA 147-151
53. Potter J., and Higginson I.J. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer 43 (2004) 247-257
54. Silvestri G.A., Sherman C., Williams T., et al. Caring for the dying patient with lung cancer. Chest 122 (2002) 1028-1036
55. Miaskowski C., Cleary J., Burney R., et al. Guideline for the management of cancer pain in adults and children (2004), American Pain Society, Glenview, IL
56. Cheran S.K., Herndon II J.E., and Patz Jr. E.F. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44 (2004) 317-325
57. Pinover W., and Coia L. Palliative radiation therapy. In: Berger A.M., Portenoy R., and Weissman D. (Eds). Principles and practice of supportive oncology (1998), Lippincott-Raven, Philadelphia, PA 603-626
58. Rosen L.S., Gordon D., Tchekmedyian S., et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 21 (2003) 3150-3157
59. Bukowski R., Rosen L., Gordon D., et al. Long-term therapy with zoledronic acid is effective and safe in reducing the risk of skeletal complications in patients with bone metastases from non-small cell lung cancer. Lung Cancer 41 suppl 2 (2003) S262-S263
60. Ginsberg R., Payne D., and Shamji F. Superior sulcus tumors. In: Aisner J., Arriagada R., Green M., Martini N., and Perry M. (Eds). Comprehensive textbook of thoracic oncology (1996), Williams &Wilkins, Baltimore, MD 375-387
61. Guerrero M., and Williams S. Pancoast tumor. E-Medicine (2004). http://www.emedicine.com/radio/topic515.htm (accessed March 23, 2007)
62. Klastersky J. Supportive care in cancer patients. In: Aisner J., Arriagada R., Green M., Martini N., and Perry M. (Eds). Comprehensive textbook of thoracic oncology (1996), Williams & Wilkins, Baltimore, MD 980-1001
63. Dewys W.D., Begg C., Lavin P.T., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69 (1980) 491-497
64. Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 18 (2002) 953-959
65. Linn B.S., Robinson D.S., and Klimas N.G. Effects of age and nutritional status on surgical outcomes in head and neck cancer. Ann Surg 207 (1988) 267-273
66. Nguyen T.V., and Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer 95 (2002) 553-562
67. Haugstvedt T.K., Viste A., Eide G.E., et al. Factors related to and consequences of weight loss in patients with stomach cancer. The Norwegian Multicenter experience. Norwegian Stomach Cancer Trial. Cancer 67 (1991) 722-729
68. Milstein D., Sapir D., Cohen Y., et al. Prognostic factors in patients with lung cancer. Isr J Med Sci 24 (1988) 588-592
69. Barber M. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract 17 (2002) 203-209
70. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
71. Lind D., Souba W., and Copeland E. Weight loss and cachexia. In: Abeloff M., Armitage J., Lichter A., and Niederhuber J. (Eds). Clinical oncology (1995), Churchill Livingstone, New York, NY 393-407
72. Cohn S., Sawitsky A., and Vartsky D. In vivo quantification of body nitrogen and body composition in cancer patients and cancer nutrition studies. Nutr Cancer 2 (1980) 67-71
73. Cohn S., Ellis K., and Vartsky D. Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr 34 (1981) 2839-2847
74. Cohn S., Gartenhaus W., and Sawitsky A. Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism 30 (1981) 222-229
75. Cohn S., Gartenhaus W., and Vartsky D. Body composition and dietary intake in neoplastic disease. Am J Clin Nutr 34 (1981) 1997-2004
76. Cohn S., Vaswani A., and Vartsky D. In vivo quantification of body nitrogen for nutritional assessment. Am J Clin Nutri 35 (1982) 1186-1191
77. Shizgal H.M. Body composition of patients with malnutrition and cancer. Summary of methods of assessment. Cancer 55 suppl (1985) 250-253
78. May P., Barber A., D'Olimpio J., et al. Reversal of cancer related wasting using oral supplementation with a combination of B-hydroxy-B-methylbutyrate, arginine, adn glutamine. Am J Surg 183 (2002) 471-479
79. Marian M. Cancer cachexia: prevalence, mechanisms, and interventions. Support Line 20 (1998) 3-12
80. Capra S., Ferguson M., and Ried K. Cancer: impact of nutrition intervention outcome-nutrition issues for patients. Nutrition 17 (2001) 769-772
81. Ovesen L., Allingstrup L., Hannibal J., et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 11 (1993) 2043-2049
82. In: McCallum P.D., Elliott L., Molseed L., and Grant B. (Eds). The clinical guide to oncology nutrition (2006), American Dietetic Association, Chicago, IL
83. Brown J.K. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum 29 (2002) 517-532
84. Zabora J., Brintzenhofeszoc K., Curbow B., et al. The prevalence of psychological distress by cancer site. Psychooncology 10 (2001) 19-28
85. Faller H., Schilling S., and Lang H. Causal attribution and adaptation among lung cancer patients. J Psychosomatic Res 39 (1995) 619-627
86. Walker M.S., Zona D.M., and Fisher E.B. Depressive symptoms after lung cancer surgery: Their relation to coping style and social support. Psychooncology 15 (2006) 684-693
87. Sarna L., Evangelista L., Tashkin D., et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest 125 (2004) 439-445
88. Miller K., and Massie M.J. Depression and anxiety. Cancer J 12 (2006) 388-397